Clifford Liongue

2.2k total citations
49 papers, 1.7k citations indexed

About

Clifford Liongue is a scholar working on Immunology, Oncology and Cell Biology. According to data from OpenAlex, Clifford Liongue has authored 49 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 24 papers in Oncology and 14 papers in Cell Biology. Recurrent topics in Clifford Liongue's work include Cytokine Signaling Pathways and Interactions (21 papers), Zebrafish Biomedical Research Applications (14 papers) and Immune Cell Function and Interaction (10 papers). Clifford Liongue is often cited by papers focused on Cytokine Signaling Pathways and Interactions (21 papers), Zebrafish Biomedical Research Applications (14 papers) and Immune Cell Function and Interaction (10 papers). Clifford Liongue collaborates with scholars based in Australia, Iraq and Malaysia. Clifford Liongue's co-authors include Alister C. Ward, Lynda A. O’Sullivan, Rowena S. Lewis, Sarah Stephenson, Monique C. Trengove, Faiza Basheer, Janani Kumar, Christopher J. Hall, Phil Crosier and Aaron P. Russell and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Clifford Liongue

47 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clifford Liongue Australia 19 763 616 517 295 219 49 1.7k
Mengkun Zhang United States 13 524 0.7× 677 1.1× 728 1.4× 681 2.3× 147 0.7× 24 1.8k
Jianxin Fu China 23 753 1.0× 794 1.3× 1.3k 2.5× 253 0.9× 128 0.6× 68 2.5k
Yanyun Zhang China 29 697 0.9× 520 0.8× 982 1.9× 94 0.3× 429 2.0× 89 2.2k
Vijaya Chaturvedi United States 24 415 0.5× 477 0.8× 1.2k 2.4× 219 0.7× 374 1.7× 39 2.0k
Sandrine Marchetti France 24 354 0.5× 336 0.5× 1.2k 2.4× 239 0.8× 375 1.7× 42 2.1k
Sophia Derdak Austria 21 630 0.8× 272 0.4× 800 1.5× 135 0.5× 97 0.4× 58 1.9k
K R Auger United States 16 879 1.2× 511 0.8× 1.5k 2.9× 389 1.3× 174 0.8× 22 2.7k
Parmesh Dutt United States 17 979 1.3× 808 1.3× 1.3k 2.6× 587 2.0× 176 0.8× 32 3.0k
Michael Kline United States 13 478 0.6× 417 0.7× 1.3k 2.5× 243 0.8× 102 0.5× 24 1.9k
Ιωάννα Μαρουλάκου United States 24 535 0.7× 660 1.1× 1.5k 2.8× 202 0.7× 499 2.3× 43 2.4k

Countries citing papers authored by Clifford Liongue

Since Specialization
Citations

This map shows the geographic impact of Clifford Liongue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clifford Liongue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clifford Liongue more than expected).

Fields of papers citing papers by Clifford Liongue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clifford Liongue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clifford Liongue. The network helps show where Clifford Liongue may publish in the future.

Co-authorship network of co-authors of Clifford Liongue

This figure shows the co-authorship network connecting the top 25 collaborators of Clifford Liongue. A scholar is included among the top collaborators of Clifford Liongue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clifford Liongue. Clifford Liongue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liongue, Clifford, et al.. (2024). B Cell Lymphoma 6 (BCL6): A Conserved Regulator of Immunity and Beyond. International Journal of Molecular Sciences. 25(20). 10968–10968. 9 indexed citations
3.
Silva, Rohini M. de, Y.I.N.S. Gunawardene, A.J. Schultz, et al.. (2024). Innovative transgenic zebrafish biosensor for heavy metal detection. Environmental Pollution. 366. 125547–125547. 2 indexed citations
4.
Liongue, Clifford, et al.. (2024). Stat3 Regulates Developmental Hematopoiesis and Impacts Myeloid Cell Function via Canonical and Non-Canonical Modalities. Journal of Innate Immunity. 16(1). 1–1. 2 indexed citations
5.
Basheer, Faiza, et al.. (2023). Zebrafish: A Relevant Genetic Model for Human Primary Immunodeficiency (PID) Disorders?. International Journal of Molecular Sciences. 24(7). 6468–6468. 3 indexed citations
6.
Liongue, Clifford, et al.. (2023). Contribution of Signal Transducer and Activator of Transcription 3 (STAT3) to Bone Development and Repair. International Journal of Molecular Sciences. 25(1). 389–389. 4 indexed citations
7.
Ward, Alister C., et al.. (2023). Analysis of Potential Non-Canonical or Alternate STAT5 Functions in Immune Development and Growth. Frontiers in Bioscience-Landmark. 28(8). 187–187. 2 indexed citations
8.
Gibert, Yann, et al.. (2022). Cytokine Receptor-Like Factor 3 (CRLF3) Contributes to Early Zebrafish Hematopoiesis. Frontiers in Immunology. 13. 910428–910428. 4 indexed citations
9.
Liongue, Clifford, et al.. (2021). SOCS Proteins in Immunity, Inflammatory Diseases, and Immune-Related Cancer. Frontiers in Medicine. 8. 727987–727987. 117 indexed citations
10.
Liongue, Clifford, et al.. (2021). STAT proteins: a kaleidoscope of canonical and non-canonical functions in immunity and cancer. Journal of Hematology & Oncology. 14(1). 198–198. 85 indexed citations
11.
Basheer, Faiza, Clifford Liongue, & Alister C. Ward. (2020). Zebrafish Bacterial Infection Assay to Study Host-Pathogen Interactions. BIO-PROTOCOL. 10(5). e3536–e3536. 4 indexed citations
12.
Gibert, Yann, Joachim Berger, Adam Smith, et al.. (2018). The ADAMTS5 Metzincin Regulates Zebrafish Somite Differentiation. International Journal of Molecular Sciences. 19(3). 766–766. 4 indexed citations
13.
Liongue, Clifford, et al.. (2014). ETV6 (TEL1) in blood cell development and malignancy. Deakin Research Online (Deakin University). 1(3). 1–7. 3 indexed citations
14.
Liongue, Clifford & Alister C. Ward. (2014). Granulocyte Colony-Stimulating Factor Receptor Mutations in Myeloid Malignancy. Frontiers in Oncology. 4. 93–93. 25 indexed citations
16.
Liongue, Clifford, Lynda A. O’Sullivan, Monique C. Trengove, & Alister C. Ward. (2012). Evolution of JAK-STAT Pathway Components: Mechanisms and Role in Immune System Development. PLoS ONE. 7(3). e32777–e32777. 127 indexed citations
17.
Liongue, Clifford, Liza B. John, & Alister C. Ward. (2011). Origins of Adaptive Immunity. Critical Reviews in Immunology. 31(1). 61–71. 6 indexed citations
18.
Liongue, Clifford, Craig Wright, Aaron P. Russell, & Alister C. Ward. (2009). Granulocyte colony-stimulating factor receptor: Stimulating granulopoiesis and much more. The International Journal of Biochemistry & Cell Biology. 41(12). 2372–2375. 80 indexed citations
19.
Liongue, Clifford & Alister C. Ward. (2007). Evolution of Class I cytokine receptors. BMC Evolutionary Biology. 7(1). 120–120. 119 indexed citations
20.
O’Sullivan, Lynda A., Clifford Liongue, Rowena S. Lewis, Sarah Stephenson, & Alister C. Ward. (2007). Cytokine receptor signaling through the Jak–Stat–Socs pathway in disease. Molecular Immunology. 44(10). 2497–2506. 253 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026